This comprehensive analysis reviewed data from multiple growth hormone (GH) registries to assess the long-term safety of GH treatment in children and adults. The study found no increased risk of mortality, stroke, or new malignancies in GH-treated individuals without pre-existing risk factors. However, an elevated risk of secondary neoplasms was
